glp-1 obesity drug news The revolution: What UAB researchers are discovering about how these drugs work Weight loss drugs and addiction:
Description
3 Department of Physical Chemistry and Technology of Polymers, Silesian University of Technology, Gliwice, Poland
Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments
Additionally, a systematic review by Drant et al
Gastroparesis is in fact a major determinant of post-prandial glucose excursions, and a cause for upper gastrointestinal symptoms
One medication is rarely enough for sustained control over decades
Effect of dulaglutide on cognitive impairment in type 2 diabetes: An exploratory analysis of the REWIND trial
